ATC Group: J01FA01 Erythromycin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01FA01 in the ATC hierarchy

Level	Code	Title
`1`	J	Antiinfectives for systemic use
`2`	J01	Antibacterials for systemic use
`3`	J01F	Macrolides, lincosamides and streptogramins
`4`	J01FA	Macrolides
`5`	J01FA01	Erythromycin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
PAREN	Parenteral	1 g

Active ingredients in J01FA01

Active Ingredient
Erythromycin
Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.

Related product monographs

Document	Type	Information Source
ERMYCIN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
ERY-TAB Delayed-release tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)
ERYTHROCIN Film coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
ERYTHROPED SF Granules	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
PORPHYROCIN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)